The FDA approved Hibsago (bepirovirsen; GSK), the first antisense oligonucleotide for chronic hepatitis B, for use with a nucleos (t)ide analogue in adults without cirrhosis, the agency announced ...

The FDA approved bepirovirsen, the first antisense oligonucleotide for chronic hepatitis B, offering a new treatment with functional cure potential. Bepirovirsen is specifically approved for patients ...

In a blog post and accompanying YouTube video, AMD has just revealed that it is bringing its ML-powered upscaling technology, FSR 4.1, to the Xbox Series S and X consoles, to Radeon RX 6000-series ...

Apothecary Pharma is recalling 22 vials of compounded tirzepatide and one NAD+ vial nationwide, citing a lack of assurance of sterility. A North Carolina outsourcing facility is pulling 22 vials of ...

Neha Bora and similar Maoists do not accept the Indian Constitution at all. Their objective is to attack constitutional institutions ...

North Korean hackers are using a post-quantum cryptographic mechanism to secure malicious payload delivery in new operations that combine old and new malware.

Higher ultraprocessed food intake is associated with greater odds of vascular brain injury and adiposity, but not cognitive performance.

The FDA has approved Hibsago (bepirovirsen) as an add-on antisense oligonucleotide therapy to help noncirrhotic adults with chronic hepatitis B achieve functional cure.

Apothecary Pharma is recalling 23 vials of compounded injectable drugs distributed nationwide because their sterility cannot be assured, according to the Food and Drug Administration.

At ISC 2016, Edward Ahearne, a Senior Analytical Scientist in AstraZeneca's Early Chemical Development New Modalities group, was interviewed by LCGC International on why his team combined automated ...

The Stellar Bell upgrade (Protocol 30) adds W addresses, ML-DSA support, and millisecond timing. Mainnet vote is Nov. 23.

AI/ML-based adaptive fraud analytics leads growth as real-time payments, generative-AI-driven fraud, tighter regulation and vendor consolidation reshape the marketDublin, Oct. 21, 2026 (GLOBE NEWSWIRE ...